The best method of anticoagulation for patients with peripheral artery disease (PAD) is still a
topic of interest for physicians. We conducted a meta-analysis to compare the effects of …

Background Several observational studies have shown that the inappropriate dosing use of
direct oral anticoagulants (DOACs) in atrial fibrillation (AF) that does not conform to …

Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …

Die Arzneimitteltherapie bei Frauen im gebärfähigen Alter ist jedoch schlecht dokumentiert.
Das geht aus unseren Umfrageergebnissen hervor. Nur wenige Frauen, die bereits vor ihrer …

Several observational studies have compared the effectiveness and safety outcomes
between nonvitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists …

Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …

Background: Current evidence regarding the application of direct oral anticoagulants
(DOACs) vs. vitamin K antagonists (VKAs) on the fracture risk is inconsistent. Therefore, we …

Background: Given the huge burden of atrial fibrillation (AF) and AF-related stroke in Asia,
stroke prevention represents an urgent issue in this region. We herein performed a network …

Atherosclerosis is associated with a haemostatic imbalance characterized by excessive
activation of pro‐inflammatory and pro‐coagulant pathways. Non‐vitamin K antagonists oral …

Although several studies have assessed the effect of non‐vitamin K antagonist oral
anticoagulants (NOACs) relative to that of vitamin K antagonists (VKAs) in patients with left …